Su H, Peng Y, Wu Y, Zeng X
Front Immunol. 2025; 16:1541467.
PMID: 39911397
PMC: 11794508.
DOI: 10.3389/fimmu.2025.1541467.
Crucitta S, Cucchiara F, Marconcini R, Bulleri A, Manacorda S, Capuano A
Front Mol Biosci. 2024; 11:1288677.
PMID: 38633217
PMC: 11021649.
DOI: 10.3389/fmolb.2024.1288677.
Tang C, He X, Jia L, Zhang X
Noncoding RNA Res. 2023; 9(1):105-115.
PMID: 38075205
PMC: 10700123.
DOI: 10.1016/j.ncrna.2023.10.007.
Wang J, He P, Tian Q, Luo Y, He Y, Liu C
Neural Regen Res. 2023; 18(9):2029-2036.
PMID: 36926729
PMC: 10233773.
DOI: 10.4103/1673-5374.367831.
Wang Y, Li M, Wang G, Wu H
Front Oncol. 2023; 12:1091383.
PMID: 36741734
PMC: 9890054.
DOI: 10.3389/fonc.2022.1091383.
Interplay between programmed death-ligand 1 and non-coding RNAs.
Ghafouri-Fard S, Shoorei H, Hussen B, Poornajaf Y, Taheri M, Sharifi G
Front Immunol. 2022; 13:982902.
PMID: 36405753
PMC: 9667550.
DOI: 10.3389/fimmu.2022.982902.
MiR-4763-3p targeting as a Potential Biomarker and Therapeutic Target for Schizophrenia.
Wang J, Qi W, Shi H, Huang L, Ning F, Wang F
Aging Dis. 2022; 13(4):1278-1292.
PMID: 35855328
PMC: 9286908.
DOI: 10.14336/AD.2022.0103.
Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
Yang Z, Liu T, Ren X, Yang M, Tu C, Li Z
Cell Cycle. 2022; 21(20):2121-2131.
PMID: 35699451
PMC: 9519004.
DOI: 10.1080/15384101.2022.2087755.
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).
Zeng Z, Chen Y, Geng X, Zhang Y, Wen X, Yan Q
Int J Oncol. 2022; 60(6).
PMID: 35506469
PMC: 9083885.
DOI: 10.3892/ijo.2022.5366.
Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse.
Dobosz P, Stempor P, Moreno M, Bulgakova N
Heredity (Edinb). 2022; 129(1):64-74.
PMID: 35459932
PMC: 9273643.
DOI: 10.1038/s41437-022-00533-1.
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics.
Yamaguchi H, Hsu J, Yang W, Hung M
Nat Rev Clin Oncol. 2022; 19(5):287-305.
PMID: 35132224
DOI: 10.1038/s41571-022-00601-9.
Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach.
Lambrou G, Poulou M, Giannikou K, Themistocleous M, Zaravinos A, Braoudaki M
Cancers (Basel). 2021; 13(21).
PMID: 34771655
PMC: 8583574.
DOI: 10.3390/cancers13215491.
GATA1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p.
Li Y, Zhai Y, Chen Y
J Ovarian Res. 2021; 14(1):108.
PMID: 34425872
PMC: 8383404.
DOI: 10.1186/s13048-021-00856-3.
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K, Hana D, Chou J, Singh C, Mackiewicz A, Kaczmarek M
Front Immunol. 2021; 12:656364.
PMID: 34122412
PMC: 8190405.
DOI: 10.3389/fimmu.2021.656364.
miR-34a inhibits melanoma growth by targeting ZEB1.
Xu Y, Guo B, Liu X, Tao K
Aging (Albany NY). 2021; 13(11):15538-15547.
PMID: 34102608
PMC: 8221330.
DOI: 10.18632/aging.203114.
The comprehensive landscape of miR-34a in cancer research.
Li S, Wei X, He J, Cao Q, Du D, Zhan X
Cancer Metastasis Rev. 2021; 40(3):925-948.
PMID: 33959850
DOI: 10.1007/s10555-021-09973-3.
LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation.
Zhao H, Li J, Yan X, Bian X
Cancer Manag Res. 2021; 13:3493-3501.
PMID: 33911899
PMC: 8075183.
DOI: 10.2147/CMAR.S274615.
MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma.
Zheng B, Chen T
Open Life Sci. 2021; 15(1):274-283.
PMID: 33817216
PMC: 7874546.
DOI: 10.1515/biol-2020-0024.
Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation.
Ishikawa M, Iwasaki M, Sakamoto A, Ma D
BMC Anesthesiol. 2021; 21(1):71.
PMID: 33750303
PMC: 7941705.
DOI: 10.1186/s12871-021-01294-w.
Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.
Ma T, Hu C, Lal B, Zhou W, Ma Y, Ying M
Cancer Res. 2021; 81(9):2457-2469.
PMID: 33574085
PMC: 8137560.
DOI: 10.1158/0008-5472.CAN-20-2489.